Fdl C News Today

A drug targeting mRNA essential for APO C-III production provided a 50% reduction in triglycerides in BRIDGE-TIMI 73a, the largest ever observed in a controlled trial.

Despite lower prevalence rates, women with steatotic liver disease related to alcohol consumption had close to double the risk of dying than men with the same condition.

Light physical activity may be a crucial intervention target to attenuate the risk for elevated lipid levels and their sequelae in the pediatric population, study said.

Data from four tirzepatide pivotal trials in people with type 2 diabetes showed ≥15% weight loss in 25% of those on tirzepatide, with seven factors significantly linked with greater weight loss.

Participants taking estetrol experienced beneficial changes across a variety of metabolic measures, according to a new study presented at the Menopause Society.

"Good" cholesterol at low or high levels is linked to dementia risk in older adults, but there was no association between dementia and levels of "bad" cholesterol

Fluctuations in specific blood lipid levels is linked to a significantly increased risk for dementia in new findings that further confirm the well-established link between heart health and brain health.

A single injection every 3 months of a novel drug that targets the lipid metabolism enzyme ANGPTL3 resulted in substantial reductions in LDL cholesterol in patients with HoFH in the phase 2 GATEWAY trial.

Children and adolescents with homozygous familial hypercholesterolemia could benefit from lomitapide therapy, suggests a trial, although safety concerns and upcoming novel drugs question its place.

A simple-to-obtain measure of insulin resistance can stratify cardiac risk in patients who have undergone coronary artery bypass graft surgery to better guide follow-up care.